Mon–Thu 8am–4:30pm CT · Fri 8am–3pm CT
Clinical Trial · NCT02805608
Overview
The sensitivity and specificity of uPAR PET/CT with the radioligand 68GaNOTA-AE105 and FDG PET/MRI for preoperative detection of regional lymph node metastases in urinary bladder cancer
Phase
Phase 2
Contacts
Dorthe Skovgaard, Md, PhD (PRINCIPAL_INVESTIGATOR)
ClinicalTrials.gov
NCT02805608Drug / Compound
Eligibility
Help us improve your experience